ALPHA-BUTYL-OMEGA-HYDROXYPOLY(OXYPROPYLENE)
General Information
Mainterm | ALPHA-BUTYL-OMEGA-HYDROXYPOLY(OXYPROPYLENE) |
CAS Reg.No.(or other ID) | 9003-13-8 |
Regnum |
178.3910 176.180 176.210 178.3570 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 24752 |
IUPAC Name | 1-(1-butoxypropan-2-yloxy)propan-2-ol |
InChI | InChI=1S/C10H22O3/c1-4-5-6-12-8-10(3)13-7-9(2)11/h9-11H,4-8H2,1-3H3 |
InChI Key | CUVLMZNMSPJDON-UHFFFAOYSA-N |
Canonical SMILES | CCCCOCC(C)OCC(C)O |
Molecular Formula | C10H22O3 |
Wikipedia | 1-(2-butoxy-1-methylethoxy)propan-2-ol |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 190.283 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 8 |
Complexity | 106.0 |
CACTVS Substructure Key Fingerprint | A A A D c e B w M A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G g A A C A A A C B S g g A I C A A A A B g A A A A A A A A A A A A A A A A A A A A A A A A A B E A A A A A A C A A A E A A A D A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 38.7 |
Monoisotopic Mass | 190.157 |
Exact Mass | 190.157 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 13 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9382 |
Human Intestinal Absorption | HIA+ | 0.9938 |
Caco-2 Permeability | Caco2+ | 0.6706 |
P-glycoprotein Substrate | Substrate | 0.5620 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.5769 |
Non-inhibitor | 0.5331 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8808 |
Distribution | ||
Subcellular localization | Mitochondria | 0.5793 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8715 |
CYP450 2D6 Substrate | Non-substrate | 0.8127 |
CYP450 3A4 Substrate | Non-substrate | 0.5929 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8909 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9276 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9322 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8756 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8753 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9573 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8693 |
Non-inhibitor | 0.5806 | |
AMES Toxicity | Non AMES toxic | 0.8646 |
Carcinogens | Carcinogens | 0.5370 |
Fish Toxicity | Low FHMT | 0.6632 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8671 |
Honey Bee Toxicity | High HBT | 0.7168 |
Biodegradation | Ready biodegradable | 0.6162 |
Acute Oral Toxicity | III | 0.8715 |
Carcinogenicity (Three-class) | Non-required | 0.7389 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -1.7464 | LogS |
Caco-2 Permeability | 1.0366 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.0777 | LD50, mol/kg |
Fish Toxicity | 2.4024 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.4082 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Organic oxygen compounds |
Class | Organooxygen compounds |
Subclass | Alcohols and polyols |
Intermediate Tree Nodes | Not available |
Direct Parent | Secondary alcohols |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Secondary alcohol - Ether - Dialkyl ether - Hydrocarbon derivative - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as secondary alcohols. These are compounds containing a secondary alcohol functional group, with the general structure HOC(R)(R') (R,R'=alkyl, aryl). |
From ClassyFire